These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37894348)

  • 1. Heterogeneity in the Metastatic Microenvironment: JunB-Expressing Microglia Cells as Potential Drivers of Melanoma Brain Metastasis Progression.
    Adir O; Sagi-Assif O; Meshel T; Ben-Menachem S; Pasmanik-Chor M; Hoon DSB; Witz IP; Izraely S
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Vicious Cycle of Melanoma-Microglia Crosstalk: Inter-Melanoma Variations in the Brain-Metastasis-Promoting IL-6/JAK/STAT3 Signaling Pathway.
    Izraely S; Ben-Menachem S; Malka S; Sagi-Assif O; Bustos MA; Adir O; Meshel T; Chelladurai M; Ryu S; Ramos RI; Pasmanik-Chor M; Hoon DSB; Witz IP
    Cells; 2023 May; 12(11):. PubMed ID: 37296634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The melanoma brain metastatic microenvironment: aldolase C partakes in shaping the malignant phenotype of melanoma cells - a case of inter-tumor heterogeneity.
    Izraely S; Ben-Menachem S; Sagi-Assif O; Meshel T; Malka S; Telerman A; Bustos MA; Ramos RI; Pasmanik-Chor M; Hoon DSB; Witz IP
    Mol Oncol; 2021 May; 15(5):1376-1390. PubMed ID: 33274599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metastatic microenvironment: Melanoma-microglia cross-talk promotes the malignant phenotype of melanoma cells.
    Izraely S; Ben-Menachem S; Sagi-Assif O; Telerman A; Zubrilov I; Ashkenazi O; Meshel T; Maman S; Orozco JIJ; Salomon MP; Marzese DM; Pasmanik-Chor M; Pikarski E; Ehrlich M; Hoon DSB; Witz IP
    Int J Cancer; 2019 Feb; 144(4):802-817. PubMed ID: 29992556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormally expressed JunB transactivated by IL-6/STAT3 signaling promotes uveal melanoma aggressiveness via epithelial-mesenchymal transition.
    Gong C; Shen J; Fang Z; Qiao L; Feng R; Lin X; Li S
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29899166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR9 expression and secretion of LIF by prostate cancer cells stimulates accumulation and activity of polymorphonuclear MDSCs.
    Won H; Moreira D; Gao C; Duttagupta P; Zhao X; Manuel E; Diamond D; Yuan YC; Liu Z; Jones J; D'Apuzzo M; Pal S; Kortylewski M
    J Leukoc Biol; 2017 Aug; 102(2):423-436. PubMed ID: 28533357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MCP-1/CCR2 axis inhibition sensitizes the brain microenvironment against melanoma brain metastasis progression.
    Pozzi S; Scomparin A; Ben-Shushan D; Yeini E; Ofek P; Nahmad AD; Soffer S; Ionescu A; Ruggiero A; Barzel A; Brem H; Hyde TM; Barshack I; Sinha S; Ruppin E; Weiss T; Madi A; Perlson E; Slutsky I; Florindo HF; Satchi-Fainaro R
    JCI Insight; 2022 Sep; 7(17):. PubMed ID: 35980743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A distinct pattern of growth and RAC1 signaling in melanoma brain metastasis cells.
    Stejerean-Todoran I; Gimotty PA; Watters A; Brafford P; Krepler C; Godok T; Li H; Bonilla Del Rio Z; Zieseniss A; Katschinski DM; Sertel SM; Rizzoli SO; Garman B; Nathanson KL; Xu X; Chen Q; Oswald JH; Lotem M; Mills GB; Davies MA; Schön MP; Bogeski I; Herlyn M; Vultur A
    Neuro Oncol; 2023 Apr; 25(4):674-686. PubMed ID: 36054930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglial Janus kinase/signal transduction and activator of transcription 3 pathway activity directly impacts astrocyte and spinal neuron characteristics.
    Molet J; Mauborgne A; Diallo M; Armand V; Geny D; Villanueva L; Boucher Y; Pohl M
    J Neurochem; 2016 Jan; 136(1):133-47. PubMed ID: 26440453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of cell surface GD3 ganglioside phenotype is associated with human melanoma brain metastasis.
    Ramos RI; Bustos MA; Wu J; Jones P; Chang SC; Kiyohara E; Tran K; Zhang X; Stern SL; Izraely S; Sagi-Assif O; Witz IP; Davies MA; Mills GB; Kelly DF; Irie RF; Hoon DSB
    Mol Oncol; 2020 Aug; 14(8):1760-1778. PubMed ID: 32358995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting Immunosuppressive Cell Communication Patterns Reveals JunB Proto-Oncogene (JUNB) Shaping a Non-Inflamed Tumor Microenvironment.
    Chen H; Chen G
    Front Genet; 2022; 13():883583. PubMed ID: 35812726
    [No Abstract]   [Full Text] [Related]  

  • 12. Leukemia inhibitory factor regulates trophoblast giant cell differentiation via Janus kinase 1-signal transducer and activator of transcription 3-suppressor of cytokine signaling 3 pathway.
    Takahashi Y; Takahashi M; Carpino N; Jou ST; Chao JR; Tanaka S; Shigeyoshi Y; Parganas E; Ihle JN
    Mol Endocrinol; 2008 Jul; 22(7):1673-81. PubMed ID: 18451094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of LIF (leukemia inhibitory factor) expression in malignant melanoma.
    Kuphal S; Wallner S; Bosserhoff AK
    Exp Mol Pathol; 2013 Oct; 95(2):156-65. PubMed ID: 23831429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophages/Microglia Represent the Major Source of Indolamine 2,3-Dioxygenase Expression in Melanoma Metastases of the Brain.
    Herrera-Rios D; Mughal SS; Teuber-Hanselmann S; Pierscianek D; Sucker A; Jansen P; Schimming T; Klode J; Reifenberger J; Felsberg J; Keyvani K; Brors B; Sure U; Reifenberger G; Schadendorf D; Helfrich I
    Front Immunol; 2020; 11():120. PubMed ID: 32117271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficient leukemia inhibitory factor signaling in muscle precursor cells from patients with type 2 diabetes.
    Broholm C; Brandt C; Schultz NS; Nielsen AR; Pedersen BK; Scheele C
    Am J Physiol Endocrinol Metab; 2012 Jul; 303(2):E283-92. PubMed ID: 22649064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interplay between glioblastoma and microglia cells leads to endothelial cell monolayer dysfunction via the interleukin-6-induced JAK2/STAT3 pathway.
    Couto M; Coelho-Santos V; Santos L; Fontes-Ribeiro C; Silva AP; Gomes CMF
    J Cell Physiol; 2019 Nov; 234(11):19750-19760. PubMed ID: 30937892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JunB as a downstream mediator of PTHrP actions in cementoblasts.
    Berry JE; Ealba EL; Pettway GJ; Datta NS; Swanson EC; Somerman MJ; McCauley LK
    J Bone Miner Res; 2006 Feb; 21(2):246-57. PubMed ID: 16418780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning of JunA and JunB and comparison of mRNA expression levels in two Xiphophorus melanoma models.
    Heater SJ; Rains JD; Braden AR; Gilmer SM; Walter RB
    Zebrafish; 2006; 3(1):53-63. PubMed ID: 18248246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystatin C takes part in melanoma-microglia cross-talk: possible implications for brain metastasis.
    Moshe A; Izraely S; Sagi-Assif O; Prakash R; Telerman A; Meshel T; Carmichael T; Witz IP
    Clin Exp Metastasis; 2018 Aug; 35(5-6):369-378. PubMed ID: 29722001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosome.
    Marzese DM; Liu M; Huynh JL; Hirose H; Donovan NC; Huynh KT; Kiyohara E; Chong K; Cheng D; Tanaka R; Wang J; Morton DL; Barkhoudarian G; Kelly DF; Hoon DS
    Pigment Cell Melanoma Res; 2015 Jan; 28(1):82-93. PubMed ID: 25169209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.